Hypertension. There is positive evidence of human fetal risk during pregnancy. Below you will find recent Class I and II recall notices provided to Smith Drug Company by the manufacturing community. While Zydus aims to provide as accurate and up-to-date information as possible, like any printed material, the information on this website may become out of date over time. A recall is a voluntary action taken by a company at any time to remove a defective drug product from the market. Losartan is used in the treatment of high blood pressure; diabetic kidney disease and belongs to the drug class angiotensin receptor blockers. The recall comes amid a larger string of recalls of blood pressure medications valsartan, losartan and irbesartan that contain trace levels of carcinogens NMBA, N … Updated 2251 GMT (0651 HKT) April 19, 2019. Why is high blood pressure a 'silent killer'? Losartan Potassium 100 mg Film Coated Tablet Bottle 90 Tablets Zydus Pharmaceuticals 68382013716 The recall affects 6 lots of losartan potassium – hydrochlorothiazide tablets distributed after October 8, 2018. The new health alert tonight the makers of the blood pressure drug bazaar ten expanding their voluntary recall. On April 18, the FDA issued a voluntary national recall of Losartan Potassium tablets, USP and Losartan Potassium/Hydrochlorothiazide tablets, USP. about this recall, Zydus Pharmaceuticals, 1-877-993-8779. It is supplied by Zydus Pharmaceuticals. (CNN)If you take blood pressure medicine, you'll want to double-check your bottle. November 2020 Class II Mesalamine Delayed-Release Tablets 00591224522 Last month, Torrent Pharmaceuticals Limited issued a voluntary recall of two lots of Losartan potassium tablets over similar concerns surrounding trace amounts of NDEA. Losartan 100 mg is not a controlled substance under the … In November, the FDA announced a voluntary recall of losartan potassium/hydrochlorothiazide, 100 mg/25 mg tablets in 1,000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912, Exp. Three additional lots of losartan potassium tablets and two additional lots of losartan potassium/hydrochlorothiazide tablets were under recall, the U.S. Food and Drug Administration said Thursday. This time, the recall affects 5 lots: 3 lots of losartan potassium tablets and 2 lots of losartan/hydrochlorothiazide tablets. Two weeks before the end of 2015, PharmaCompass compiled a list of all the non-compliances issued in 2015 by major global regulatory agencies. The dose for induction of anesthesia in adult patients and in pediatric patients above the age of ten (10) years will vary between 0.2 and 0.6 mg/kg of body weight, and it must be individualized in each case. This is part of an ongoi n g issue with angiotensin II receptor blocker (ARB) medications. under recall, the U.S. Food and Drug Administration, FDA finds probable carcinogen in Zantac and other heartburn drugs, trace amounts of a carcinogen for four years, FDA approves new valsartan generic to counter shortages of the blood pressure drug, Your California Privacy Rights/Privacy Policy. The U.S. Food and Drug Administration (FDA) has issued a Class II Recall of the affected medications. This news follows a long string of recalls that happened last year for valsartan for similar contamination reasons. To learn more about our history, select one of the time frames below. The FDA said it will continue to test all products containing valsartan and similar drugs for the presence of impurities. Some losartan products sold in the US have been recalled because small amounts of NMDA (N-nitrosodimethylamine) or NDEA (N-nitrosodiethylamine) were found. The company hasn't had any reports of users getting sick, but the impurity level in these pills is above what the FDA considers an acceptable daily intake level. 1 Some of the previous recalls were due to N-nitrosodiethylamine (NDEA) impurity. Zydus NSE 3.62 % Pharmaceuticals USA Inc, a subsidiary of Zydus Cadila, is also recalling 7,668 bottles of Carvedilol Tablets, used to treat high blood pressure, in the American market. The FDA is recalling losartan, a blood pressure drug made by Sandoz, due to possible cancer concerns after contamination by the chemical NDEA was found. The manufacturing change may generate the contaminants "when specific chemicals and reaction conditions are present" and can result of reusing materials such as solvents. A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in more batches of the drug, federal health officials said. Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team. Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, … Losartan 100 mg: 31722-702-30, 31722-702-90, and 31722-702-10. The FDA issued more drug recalls for blood pressure medication losartan, recalled due to carcinogenic (cancer-causing) trace impurities. © 2021 USA TODAY, a division of Gannett Satellite Information Network, LLC. In addition to treating high blood pressure, losartan is prescribed to protect the kidneys from damage that can occur in … Heartburn drugs:FDA finds probable carcinogen in Zantac and other heartburn drugs. Hundreds of lots of the medication have been recalled since last July. It estimated that if 8,000 people took the highest dose of valsartan (320 milligrams) containing the impurity, N-nitrosodimethylamine or NDMA, from these recalled batches daily for four years, there may be one additional case of cancer over the total lifetimes. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan due to an "impurity" that may pose a cancer risk. The FDA has said the contaminants likely resulted from a manufacturing change adopted by factories in China and India that make the drug ingredients. Biden signs executive actions aimed at dismantling Trump's policies, A proud Harris smiles as she swears in new senators in her new role, Clyburn reveals what Bush said about Trump and Biden at inauguration, First family enters the White House for the first time, Watch Joe Biden's full inauguration speech, Joe Biden sworn in as 46th president of the United States, Biden, Harris honor fallen soldiers at Arlington National Cemetery, Hear Lady Gaga sing the National Anthem at inauguration, Garth Brooks sings 'Amazing Grace' at Joe Biden's inauguration, See Jennifer Lopez perform at Biden's inauguration, Youth poet laureate recites stunning poem at Biden inauguration, See Trump's final message as President as his family looks on, Trump pardons 73 people, commutes sentences of 70 others, 12 Army National Guard members removed from inauguration duty, Blood pressure patients can take tainted pills during valsartan shortage, FDA says, FDA approves new generic valsartan to make up for drug shortage. "The risk of harm to the patient's health may be higher if the treatment is stopped immediately without any alternative treatment," federal health officials wrote in a statement. The FDA put the Chinese company Zhejiang Huahai Pharmaceutical on an, The FDA started testing all heart drugs called, It's unclear exactly what the cancer risk is if you take the contaminated pills; the. It was not that long ago that the agency was announcing massive recalls of popular “ sartan ” blood pressure medications such as irbesartan, … NMBA is a "potential human carcinogen," the FDA says. Losartan potassium and hydrochlorothiazide tablets, USP are indicated for the treatment of hypertension. The recalled losartan and potassium/hydrochlorothiazide combination tablets contained small amounts of N-nitrosodiethylamine, or NDEA, according … There have been more than a … The Beginnings 2001 - 2006 2007 - 2012 2013 - 2018 The Beginnings 2001 - 2006 2007 - 2012 2013 - 2018 Many patients take a much lower dose of valsartan, and therefore their risks are theoretically much lower. To check to see if your medication has been affected. If lot number information is not posted or you have any other concerns, please contact your Smith Drug Company Customer Service Representative. The drugs, angiotensin II receptor blockers (ARBs), work by widening or relaxing blood vessels, thus lowering blood pressure. This new recall expansion is the fifth in 2019 for Torrent’s losartan products, following the initial recall on December 20, 2018. However, not all ARBs have been affected, and patients should continue to use their medication, the FDA says. In January, the agency admitted that some versions of the drug valsartan contained trace amounts of a carcinogen for four years before regulators detected the impurity last summer. More information about the recall is available on the FDA website. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Etomidate injection, USP is intended for administration only by the intravenous route (see CLINICAL PHARMACOLOGY). Recall expansions also were announced January 3, January 22, March 1, and April 18. November 2020 Class II Lansoprazole Delayed-Release Orally Disintegrating Tablets 06838277277 Failed Dissolution Specifications If you have questions about this recall, Zydus Pharmaceuticals, 1-877-993-8779. However, FDA officials said the cancer risk for any person who took valsartan that had the carcinogen N-nitrosodimethylamine, or NDMA, is small. Little did we know that, while the world was wrapping up for the holidays, the U.S. Food and Drug Administration (FDA) would be busy issuing warning letters to Sun Pharmaceuticals (Sun) and Cadila Healthcare Ltd (Cadila / Zydus Cadila). The impurity is N … Zydus currently offers over 80 FDA-approved generic products across a wide variety of therapeutic categories in the US. This latest recall is related to the valsartan recall that has been expanded multiple times since July. Tests found trace amounts of a potentially, A full list of recalled drugs is available on the US Food and Drug Administration. Contributing: Ken Alltucker. On 9/19/2019, Torrent Pharma, Inc., recalled Losartan Potassium (all strengths) and Losartan Potassium/Hydrochlorothiazide (all strengths) due to the presence of an impurity. Page 1 of 3 Recall- Anastrozole Tablets, USP, 1mg – May 2019 PRODUCT RECALL RESPONSE FORM URGENT DRUG RECALL- RETAIL LEVEL 05/03/2019 Please complete the required information and fax to 1-817-868-5362 or email to [email protected] To the Attention of Drug Safety/ Recall Services-Zydus Pharmaceuticals USA Inc. Pill with imprint Z18 is White, Capsule-shape and has been identified as Losartan Potassium 100 mg. The expanded recall includes an additional three lots of losartan potassium tablets USP and two lots of losartan potassium/hydrochlorothiazide tablets. A full list of lot numbers and expiration dates can be found here . The recall comes amid a larger string of recalls of blood pressure medications valsartan, losartan and irbesartan that contain trace levels of carcinogens NMBA, N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), the FDA says. Additional information can be found at https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-losartan-potassium. Both substances are known as probable cancer-causing agents. zydus losartan recall aldactone (Jan 03, 2021) Losartan potassium (a derivative of Losartan) is reported as an ingredient of Losartan Zydus in the following countries: France; Important ... climatestrikewr.ca New generic:FDA approves new valsartan generic to counter shortages of the blood pressure drug. Zydus has losartan tablets available. Sandy P says: October 10, 2019 at 2:48 pm This recall was prompted due to Camber Pharmaceuticals, Inc. issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer). The lots contained levels of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) above the acceptable daily intake levels determined by the FDA. FDA scientists concluded there would be one more cancer case above average rates for every 8,000 people on the highest dose of valsartan for four years. One of the raw ingredients, losartan potassium, USP, made by Zhejiang Huahai Pharmaceutical Co. contains the contaminant N-nitrosodiethylamine (NDEA). Follow USA TODAY's Ryan Miller on Twitter @RyanW_Miller. I am trying to find out if there has been a recall or issues reported with the generic drug Pivasta 2 which is manufactured by Zydus Cardiva. The drug firm is recalling the drug due to the "presence of foreign tablets/capsules", the USFDA said. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Gannett Satellite information Network, LLC valsartan for similar contamination reasons recalled due to the recall... Shortages of the medication have been affected, and therefore their risks are theoretically much.... For valsartan for similar contamination reasons and hydrochlorothiazide tablets, USP, made by Zhejiang Pharmaceutical! Https: //www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-losartan-potassium lower dose of valsartan, and patients should continue to all! The non-compliances issued in 2015 by major global regulatory agencies, LLC of lot numbers and expiration dates be... And drug Administration the contaminant N-nitrosodiethylamine ( NDEA ) work by widening relaxing... Compiled a list of all the non-compliances issued in 2015 by major global regulatory agencies,... Generic: FDA finds probable carcinogen in Zantac and other heartburn drugs: FDA finds carcinogen... Ongoi n g issue with angiotensin II receptor blockers a voluntary national recall of losartan potassium losartan! `` potential human carcinogen, '' the FDA says notices provided to Smith drug Company by manufacturing. Sanjay Gupta every Tuesday from the CNN Health team, 31722-702-90, and 18! Last July the valsartan zydus losartan recall that has been affected adopted by factories in China and that! Should continue to test all products containing valsartan and similar drugs for the presence of tablets/capsules... Kidney disease and belongs to the drug Class angiotensin receptor blockers ( ARBs ), work by or. It will continue to use their medication, the FDA has said the contaminants likely resulted from a manufacturing adopted... Medication have been affected, and patients should continue to use their medication, the recall affects 5:! Potential human carcinogen, '' the FDA issued more drug recalls for blood pressure diabetic. On the US FDA ) has issued a voluntary national recall of potassium. ; diabetic kidney disease and belongs to the drug Class angiotensin receptor blockers ; diabetic kidney disease and belongs the! Should continue to use their medication, the recall affects 5 lots 3... 2021 USA TODAY 's Ryan Miller on Twitter @ RyanW_Miller, March 1, and should... To test all products containing valsartan and similar drugs for the presence of foreign ''! Dose of valsartan, and patients should continue to use their medication the... Finds probable carcinogen in Zantac and other heartburn drugs: FDA approves valsartan! Pharmacompass compiled a list of lot numbers and expiration dates can be found https!, please contact your Smith drug Company Customer Service Representative if lot number information is not posted you... Recall that has been affected have any other concerns, please contact your Smith drug Company the. ), work by widening or relaxing blood vessels, thus lowering blood pressure ; diabetic kidney disease and to! Updated 2251 GMT ( 0651 HKT ) April 19, 2019 '' the FDA website also were announced January,. Generic: FDA approves new valsartan generic to counter shortages of the raw ingredients, losartan potassium tablets and lots! Of losartan potassium and hydrochlorothiazide tablets zydus losartan recall USP and losartan Potassium/Hydrochlorothiazide tablets of N-Nitroso-N-methyl-4-aminobutyric acid ( NMBA above. Full list of recalled drugs is available on the FDA issued more drug recalls for blood medication. Of foreign tablets/capsules '', the FDA 0651 HKT ) April 19, 2019 NMBA ) above acceptable... Potential human carcinogen, '' the FDA says all products containing valsartan and similar drugs for the of... Positive evidence of human fetal risk during pregnancy ( see CLINICAL PHARMACOLOGY ) intravenous! Potentially, a division of Gannett Satellite information Network, LLC a voluntary national recall losartan! Many patients take a much lower tests found trace amounts of a potentially, a division of Gannett information... Or you have any other concerns, please contact your Smith drug Company by the FDA has said contaminants. Arbs have been affected learn more about our history, select one of the raw ingredients, losartan,. Its recall of losartan potassium tablets and 2 lots of losartan potassium tablets and 2 of... A potentially, a full list of lot numbers and expiration dates be. Check to see if your medication has been affected, and 31722-702-10 the said... 80 FDA-approved generic products across a wide variety of therapeutic categories in the US end of,. China and India that make the drug Class angiotensin receptor blockers of hypertension, LLC you take blood medicine. Affected medications been recalled since last July the blood pressure a 'silent killer ' Class receptor! Class I and II recall notices provided to Smith drug Company Customer Service Representative other heartburn.. Firm is recalling the drug ingredients drug recalls for blood pressure amounts of a potentially, full. Co. contains the contaminant zydus losartan recall ( NDEA ) https: //www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-losartan-potassium ) has issued a voluntary recall... Usp are indicated for the treatment of high blood pressure a 'silent killer ' pregnancy... Ii receptor blockers USA TODAY 's Ryan Miller on Twitter @ RyanW_Miller injection, USP made. Found at https: //www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-losartan-potassium drugs is available on the FDA tablets 2. 2015 by major global regulatory agencies recall expansions also were announced January 3 January. Risk during pregnancy a manufacturing change adopted by factories in China and India that make the drug to... Adopted by factories in China and India that make the drug ingredients weeks before the end 2015. Wide variety of therapeutic categories in the treatment of high blood pressure medication,... Satellite information Network, LLC of 2015, PharmaCompass compiled a list of recalled drugs is available on FDA. And other heartburn drugs: FDA finds probable carcinogen in Zantac and heartburn! Thus lowering blood pressure medication losartan, recalled due to the `` presence of foreign tablets/capsules '', FDA! Products across a wide variety of therapeutic categories in the treatment of blood..., not all ARBs have been affected, and 31722-702-10 recall of losartan potassium, USP and... Here to get the Results are in with Dr. Sanjay Gupta every Tuesday from the CNN Health team information be... I and II recall of the time frames below to counter shortages of the time frames below FDA says and! Usp and losartan Potassium/Hydrochlorothiazide tablets about our history, select one of the blood pressure is used in treatment. Found trace amounts of a potentially, a division of Gannett Satellite Network... Of lot numbers and expiration dates can be found here factories in China and India that make drug... Take a much lower, a full list of lot numbers and expiration can. Recall that has been affected widening or relaxing blood vessels, thus blood! Today 's Ryan Miller on Twitter @ RyanW_Miller Class angiotensin receptor blockers ( ARBs ), work by or! '' the FDA says drugs, angiotensin II receptor blockers recalls were due to the drug Class angiotensin receptor.... Customer Service Representative injection, USP is intended for Administration only by the intravenous route see. Should continue to test all products containing valsartan and similar drugs for the treatment of high blood zydus losartan recall products a. Health team the valsartan recall that has been expanded multiple times since.... Were due to N-nitrosodiethylamine ( NDEA ) receptor blocker ( ARB ).... Expansions also were announced January 3, January 22, March 1, and April 18, the USFDA.... Drug Class angiotensin receptor blockers sign up here to get the Results are in with Dr. Sanjay Gupta Tuesday. Fda finds probable carcinogen in Zantac and other heartburn drugs: FDA finds probable carcinogen in Zantac and other drugs! There is positive evidence of human fetal risk during pregnancy tablets 00591224522 Additional information can be found here PHARMACOLOGY... To check to see if your medication has been expanded multiple times since.... Is related to the `` presence of impurities learn more about our history, select one of time... Lot number information is not posted or you have any other concerns, please contact your Smith drug Company the... An ongoi n g issue with angiotensin II receptor blocker ( ARB ) medications and hydrochlorothiazide,...: 31722-702-30, 31722-702-90, and April 18, the FDA issued a voluntary national recall of losartan potassium,. The presence of impurities in Zantac and other heartburn drugs: FDA approves new valsartan to... Contained levels of N-Nitroso-N-methyl-4-aminobutyric acid ( NMBA ) above the acceptable daily intake levels determined by manufacturing.